On February 24, 2024, Jeffery S. Thompson notified Anika Therapeutics, Inc. of his intention to retire from the Board of Directors after 13 years of dedicated service at the end of his current term. Mr. Thompson?s retirement will be effective as of the Company?s 2024 Annual Meeting of Stockholders (the "Annual Meeting"). Following Mr. Thompson?s retirement, the Board will be comprised of seven directors, and two Class I directors will be elected at the Annual Meeting.

Mr. Thompson?s decision is not due to any disagreement with the Company with respect to any matter relating to the Company?s operations, policies or practices. In connection with Mr. Thompson?s planned retirement, John B. Henneman, III, an independent director of the Company?s Board since 2020, has been appointed Chair of the Board, effective immediately.